Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection

Nat Commun. 2020 Jan 30;11(1):604. doi: 10.1038/s41467-019-14137-7.

Abstract

Hepatitis C virus infection (HCV) represents a unique model to characterize, from early to late stages of infection, the T cell differentiation process leading to exhaustion of human CD8+ T cells. Here we show that in early HCV infection, exhaustion-committed virus-specific CD8+ T cells display a marked upregulation of transcription associated with impaired glycolytic and mitochondrial functions, that are linked to enhanced ataxia-telangiectasia mutated (ATM) and p53 signaling. After evolution to chronic infection, exhaustion of HCV-specific T cell responses is instead characterized by a broad gene downregulation associated with a wide metabolic and anti-viral function impairment, which can be rescued by histone methyltransferase inhibitors. These results have implications not only for treatment of HCV-positive patients not responding to last-generation antivirals, but also for other chronic pathologies associated with T cell dysfunction, including cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • CD8-Positive T-Lymphocytes / immunology*
  • Chronic Disease
  • Epigenesis, Genetic / drug effects
  • Gene Expression Profiling
  • Gene Regulatory Networks / drug effects
  • Glucose / metabolism
  • Hepatitis C / blood
  • Hepatitis C / genetics
  • Hepatitis C / immunology*
  • Hepatitis C / virology
  • Histone Methyltransferases / metabolism*
  • Humans
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology
  • Middle Aged
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Principal Component Analysis
  • Signal Transduction / drug effects
  • Transcription, Genetic / drug effects
  • Tumor Suppressor Protein p53 / metabolism*
  • Young Adult

Substances

  • Antiviral Agents
  • Tumor Suppressor Protein p53
  • Histone Methyltransferases
  • Ataxia Telangiectasia Mutated Proteins
  • Glucose